Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients

[1]  E. Leifer,et al.  Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. , 2021, Blood.

[2]  C. Solano,et al.  Prospective randomized study comparing myeloablative unrelated umbilical-cord blood transplant versus HLA-haploidentical related stem cell transplant for adults with hematologic malignancies. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  S. Rose-John,et al.  IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling. , 2019, Blood.

[4]  Satoshi Takahashi,et al.  Development of Pre-Engraftment Syndrome, but Not Acute Graft-versus-Host Disease, Reduces Relapse Rate of Acute Myelogenous Leukemia after Single Cord Blood Transplantation. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  J. Sugita.  HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide , 2019, International Journal of Hematology.

[6]  L. Andritsos,et al.  Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience , 2019, Leukemia & lymphoma.

[7]  F. Baron,et al.  Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen , 2018, Clinical Cancer Research.

[8]  Yuehua Wu,et al.  Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study , 2018, International journal of cancer.

[9]  D. Porter,et al.  Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract , 2016 .

[10]  R. Başar,et al.  IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. , 2016, Blood.

[11]  J. Kochenderfer,et al.  Toxicities of chimeric antigen receptor T cells: recognition and management. , 2016, Blood.

[12]  V. Bhatt,et al.  Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood? , 2016, Future oncology.

[13]  B. Wood,et al.  Cord-Blood Transplantation in Patients with Minimal Residual Disease. , 2016, The New England journal of medicine.

[14]  Chi-kong Li,et al.  Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  M. Bhatia,et al.  Effective use of tocilizumab for the treatment of steroid‐refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin‐6 , 2015, Pediatric blood & cancer.

[16]  M. Labopin,et al.  Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies , 2015, Bone Marrow Transplantation.

[17]  Michael Poidinger,et al.  High-dimensional analysis of the murine myeloid cell system , 2014, Nature Immunology.

[18]  S. Lye,et al.  A New Role for Monocytes in Modulating Myometrial Inflammation During Human Labor1 , 2014, Biology of reproduction.

[19]  P. de Vos,et al.  Monocytes and Macrophages in Pregnancy and Pre-Eclampsia , 2014, Front. Immunol..

[20]  S. Simpson,et al.  Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation , 2014, Annals of Hematology.

[21]  D. Cheuk.  Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies. , 2013, World journal of transplantation.

[22]  Soo Hyun Lee,et al.  Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  G D Long,et al.  Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment , 2013, Bone Marrow Transplantation.

[24]  B. Becher,et al.  Acquitting an APC: DCs found “not guilty” after trial by ablation , 2012, European journal of immunology.

[25]  Xin Liu,et al.  Pre‐engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies , 2012, European journal of haematology.

[26]  E. Pamer,et al.  Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.

[27]  M. Goodell,et al.  Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response , 2011, Nature Reviews Immunology.

[28]  M. Goodell,et al.  Inflammatory signals regulate hematopoietic stem cells. , 2011, Trends in immunology.

[29]  A. Zander,et al.  transplants in children with acute leukemia Comparison of outcomes of unrelated bone marrow and umbilical cord blood , 2011 .

[30]  R. Uehara,et al.  Cytokine profiles of seventeen cytokines, growth factors and chemokines in cord blood and its relation to perinatal clinical findings. , 2010, Cytokine.

[31]  G. Heller,et al.  Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  N. Gomez‐Lopez,et al.  Placental blood leukocytes are functional and phenotypically different than peripheral leukocytes during human labor. , 2010, Journal of reproductive immunology.

[33]  F. Harrell,et al.  Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  J. Wagner,et al.  Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood , 2009, British journal of haematology.

[35]  A. Nagler,et al.  Umbilical cord blood transplantation: pros, cons and beyond. , 2009, Blood reviews.

[36]  T. Kishimoto,et al.  Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial , 2008, The Lancet.

[37]  Y. Lim,et al.  Pre-engraftment Syndrome in Hematopoietic Stem Cell Transplantation , 2008, Journal of Korean medical science.

[38]  M. Ratajczak,et al.  TNF-α Is Critical to Facilitate Hemopoietic Stem Cell Engraftment and Function1 , 2008, The Journal of Immunology.

[39]  M. Ratajczak,et al.  TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. , 2008, Journal of immunology.

[40]  J. Klein,et al.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.

[41]  S. Asano,et al.  Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. , 2007, Blood.

[42]  K. Matsuo,et al.  Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults , 2007, Bone Marrow Transplantation.

[43]  Mark Ende,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[44]  Edward A Copelan,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[45]  Y. Kanda,et al.  Early Immune Reaction after Reduced-Intensity Cord-Blood Transplantation for Adult Patients , 2005, Transplantation.

[46]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[47]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[48]  Gang Tao,et al.  A Comparison Study , 2003 .

[49]  E. Gluckman.  Hematopoietic stem-cell transplants using umbilical-cord blood. , 2001, The New England journal of medicine.

[50]  A. Zander,et al.  Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. , 2001, Blood.

[51]  E. Gluckman.  Current status of umbilical cord blood hematopoietic stem cell transplantation. , 2000, Experimental hematology.

[52]  C. Larsen,et al.  Analysis of a single‐center experience with mycophenolate mofetil based immunosuppression in renal transplantation , 2000, Clinical transplantation.

[53]  J. Klein,et al.  Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. , 2000, The New England journal of medicine.

[54]  ohn,et al.  The GRAFT-VERSUS-HOST DISEASE IN CHILDREN WHO HAVE RECEIVED A CORD-BLOOD OR BONE MARROW TRANSPLANT FROM AN HLA-IDENTICAL SIBLING , 2000 .

[55]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[56]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[57]  C. Pochedly.  Recognition and Management , 1971 .